Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020

Abstract Background Estimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). Thi...

Full description

Bibliographic Details
Main Authors: Stefano Guzzinati, Saverio Virdone, Roberta De Angelis, Chiara Panato, Carlotta Buzzoni, Riccardo Capocaccia, Silvia Francisci, Anna Gigli, Manuel Zorzi, Giovanna Tagliabue, Diego Serraino, Fabio Falcini, Claudia Casella, Antonio Giampiero Russo, Fabrizio Stracci, Bianca Caruso, Maria Michiara, Anna Luisa Caiazzo, Marine Castaing, Stefano Ferretti, Lucia Mangone, Giuseppa Rudisi, Flavio Sensi, Guido Mazzoleni, Fabio Pannozzo, Rosario Tumino, Mario Fusco, Paolo Ricci, Gemma Gola, Adriano Giacomin, Francesco Tisano, Giuseppa Candela, Anna Clara Fanetti, Filomena Pala, Antonella Sutera Sardo, Massimo Rugge, Laura Botta, Luigino Dal Maso
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-4053-y
_version_ 1828969506242822144
author Stefano Guzzinati
Saverio Virdone
Roberta De Angelis
Chiara Panato
Carlotta Buzzoni
Riccardo Capocaccia
Silvia Francisci
Anna Gigli
Manuel Zorzi
Giovanna Tagliabue
Diego Serraino
Fabio Falcini
Claudia Casella
Antonio Giampiero Russo
Fabrizio Stracci
Bianca Caruso
Maria Michiara
Anna Luisa Caiazzo
Marine Castaing
Stefano Ferretti
Lucia Mangone
Giuseppa Rudisi
Flavio Sensi
Guido Mazzoleni
Fabio Pannozzo
Rosario Tumino
Mario Fusco
Paolo Ricci
Gemma Gola
Adriano Giacomin
Francesco Tisano
Giuseppa Candela
Anna Clara Fanetti
Filomena Pala
Antonella Sutera Sardo
Massimo Rugge
Laura Botta
Luigino Dal Maso
author_facet Stefano Guzzinati
Saverio Virdone
Roberta De Angelis
Chiara Panato
Carlotta Buzzoni
Riccardo Capocaccia
Silvia Francisci
Anna Gigli
Manuel Zorzi
Giovanna Tagliabue
Diego Serraino
Fabio Falcini
Claudia Casella
Antonio Giampiero Russo
Fabrizio Stracci
Bianca Caruso
Maria Michiara
Anna Luisa Caiazzo
Marine Castaing
Stefano Ferretti
Lucia Mangone
Giuseppa Rudisi
Flavio Sensi
Guido Mazzoleni
Fabio Pannozzo
Rosario Tumino
Mario Fusco
Paolo Ricci
Gemma Gola
Adriano Giacomin
Francesco Tisano
Giuseppa Candela
Anna Clara Fanetti
Filomena Pala
Antonella Sutera Sardo
Massimo Rugge
Laura Botta
Luigino Dal Maso
author_sort Stefano Guzzinati
collection DOAJ
description Abstract Background Estimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). This study aims to provide estimates of complete cancer prevalence in Italy by sex, age, and time since diagnosis for all cancers combined, and for selected cancer types. Projections were made up to 2020, overall and by time since diagnosis. Methods Data were from 27 Italian population-based cancer registries, covering 32% of the Italian population, able to provide at least 7 years of registration as of December 2009 and follow-up of vital status as of December 2013. The data were used to compute the limited-duration prevalence, in order to estimate the complete prevalence by means of the COMPREV software. Results In 2010, 2,637,975 persons were estimated to live in Italy after a cancer diagnosis, 1.2 million men and 1.4 million women, or 4.6% of the Italian population. A quarter of male prevalent cases had prostate cancer (n = 305,044), while 42% of prevalent women had breast cancer (n = 604,841). More than 1.5 million people (2.7% of Italians) were alive since 5 or more years after diagnosis and 20% since ≥15 years. It is projected that, in 2020 in Italy, there will be 3.6 million prevalent cancer cases (+ 37% vs 2010). The largest 10-year increases are foreseen for prostate (+ 85%) and for thyroid cancers (+ 79%), and for long-term survivors diagnosed since 20 or more years (+ 45%). Among the population aged ≥75 years, 22% will have had a previous cancer diagnosis. Conclusions The number of persons living after a cancer diagnosis is estimated to rise of approximately 3% per year in Italy. The availability of detailed estimates and projections of the complete prevalence are intended to help the implementation of guidelines aimed to enhance the long-term follow-up of cancer survivors and to contribute their rehabilitation needs.
first_indexed 2024-12-14T12:32:00Z
format Article
id doaj.art-bd972314970a4a90a39a3bda3ea8f928
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-14T12:32:00Z
publishDate 2018-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-bd972314970a4a90a39a3bda3ea8f9282022-12-21T23:01:10ZengBMCBMC Cancer1471-24072018-02-0118111310.1186/s12885-018-4053-yCharacteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020Stefano Guzzinati0Saverio Virdone1Roberta De Angelis2Chiara Panato3Carlotta Buzzoni4Riccardo Capocaccia5Silvia Francisci6Anna Gigli7Manuel Zorzi8Giovanna Tagliabue9Diego Serraino10Fabio Falcini11Claudia Casella12Antonio Giampiero Russo13Fabrizio Stracci14Bianca Caruso15Maria Michiara16Anna Luisa Caiazzo17Marine Castaing18Stefano Ferretti19Lucia Mangone20Giuseppa Rudisi21Flavio Sensi22Guido Mazzoleni23Fabio Pannozzo24Rosario Tumino25Mario Fusco26Paolo Ricci27Gemma Gola28Adriano Giacomin29Francesco Tisano30Giuseppa Candela31Anna Clara Fanetti32Filomena Pala33Antonella Sutera Sardo34Massimo Rugge35Laura Botta36Luigino Dal Maso37Veneto Tumor RegistryCancer Epidemiology Unit, CRO Aviano National Cancer Institute IRCCSIstituto Superiore di Sanità (ISS)Cancer Epidemiology Unit, CRO Aviano National Cancer Institute IRCCSTuscany Cancer Registry, Clinical and Descriptive Epidemiology Unit, Cancer Prevention and Research Institute (ISPO)Dipartimento di Ricerca Epidemiologica e Medicina Molecolare (DREaMM), Fondazione IRCCS Istituto Nazionale dei TumoriIstituto Superiore di Sanità (ISS)Institute for Research on Population and Social Policies, National Research CouncilVeneto Tumor RegistryLombardy Cancer Registry, Varese Province, Cancer Registry Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei TumoriCancer Epidemiology Unit, CRO Aviano National Cancer Institute IRCCSRomagna Cancer Registry, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (Forlì), Italy-Azienda Usl della RomagnaRegistro Tumori Ligure, Epidemiologia Clinica, Ospedale Policlinico San Martino IRCCSCancer Registry of Milan, Epidemiology Unit, Agency for Health Protection of MilanPublic Health Section, Department of Experimental Medicine, University of PerugiaModena Cancer Registry, Public Health Department, AUSL ModenaParma Cancer Registry, Oncology Unit, Azienda Ospedaliera Universitaria di ParmaCancer Registry of Salerno ProvinceRegistro Tumori Integrato Catania-Messina-Siracusa-Enna, Università degli Studi di CataniaFerrara Cancer Registry, Ferrara Local Health Board, University of Ferrara, USL FerraraReggio Emilia Cancer Registry, Epidemiology unit, AUSL ASMN-IRCCS, Azienda USL di Reggio EmiliaPalermo and Province Cancer Registry, Clinical Epidemiology Unit, Azienda Ospedaliera Universitaria Policlinico “Paolo Giaccone”North Sardinia Cancer Registry, Azienda Regionale per la Tutela della SaluteSudtyrol Cancer RegistryCancer Registry of Latina Province, AUSL LatinaCancer Registry ASP RagusaCancer Registry of ASL Napoli 3 SudMantova Cancer Registry, Epidemilogy Unit, Agenzia di Tutela della Salute (ATS) della Val PadanaComo Cancer Registry, ATS InsubriaRegistro Tumori Piemonte, Provincia di Biella CPOCancer Registry of of the Province of Siracusa, Local Health Unit of SiracusaTrapani Cancer Registry, Dipartimento di Prevenzione della SaluteSondrio Cancer Registry, Health Protection AgencyNuoro Cancer Registry, RT Nuoro, ASSL Nuoro/ATS SardegnaCatanzaro Cancer Registry, Azienda Sanitaria 7Veneto Tumor RegistryDipartimento di Ricerca Epidemiologica e Medicina Molecolare (DREaMM), Fondazione IRCCS Istituto Nazionale dei TumoriCancer Epidemiology Unit, CRO Aviano National Cancer Institute IRCCSAbstract Background Estimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). This study aims to provide estimates of complete cancer prevalence in Italy by sex, age, and time since diagnosis for all cancers combined, and for selected cancer types. Projections were made up to 2020, overall and by time since diagnosis. Methods Data were from 27 Italian population-based cancer registries, covering 32% of the Italian population, able to provide at least 7 years of registration as of December 2009 and follow-up of vital status as of December 2013. The data were used to compute the limited-duration prevalence, in order to estimate the complete prevalence by means of the COMPREV software. Results In 2010, 2,637,975 persons were estimated to live in Italy after a cancer diagnosis, 1.2 million men and 1.4 million women, or 4.6% of the Italian population. A quarter of male prevalent cases had prostate cancer (n = 305,044), while 42% of prevalent women had breast cancer (n = 604,841). More than 1.5 million people (2.7% of Italians) were alive since 5 or more years after diagnosis and 20% since ≥15 years. It is projected that, in 2020 in Italy, there will be 3.6 million prevalent cancer cases (+ 37% vs 2010). The largest 10-year increases are foreseen for prostate (+ 85%) and for thyroid cancers (+ 79%), and for long-term survivors diagnosed since 20 or more years (+ 45%). Among the population aged ≥75 years, 22% will have had a previous cancer diagnosis. Conclusions The number of persons living after a cancer diagnosis is estimated to rise of approximately 3% per year in Italy. The availability of detailed estimates and projections of the complete prevalence are intended to help the implementation of guidelines aimed to enhance the long-term follow-up of cancer survivors and to contribute their rehabilitation needs.http://link.springer.com/article/10.1186/s12885-018-4053-yCancer prevalenceProjectionsSurvivorsItaly
spellingShingle Stefano Guzzinati
Saverio Virdone
Roberta De Angelis
Chiara Panato
Carlotta Buzzoni
Riccardo Capocaccia
Silvia Francisci
Anna Gigli
Manuel Zorzi
Giovanna Tagliabue
Diego Serraino
Fabio Falcini
Claudia Casella
Antonio Giampiero Russo
Fabrizio Stracci
Bianca Caruso
Maria Michiara
Anna Luisa Caiazzo
Marine Castaing
Stefano Ferretti
Lucia Mangone
Giuseppa Rudisi
Flavio Sensi
Guido Mazzoleni
Fabio Pannozzo
Rosario Tumino
Mario Fusco
Paolo Ricci
Gemma Gola
Adriano Giacomin
Francesco Tisano
Giuseppa Candela
Anna Clara Fanetti
Filomena Pala
Antonella Sutera Sardo
Massimo Rugge
Laura Botta
Luigino Dal Maso
Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
BMC Cancer
Cancer prevalence
Projections
Survivors
Italy
title Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
title_full Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
title_fullStr Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
title_full_unstemmed Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
title_short Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
title_sort characteristics of people living in italy after a cancer diagnosis in 2010 and projections to 2020
topic Cancer prevalence
Projections
Survivors
Italy
url http://link.springer.com/article/10.1186/s12885-018-4053-y
work_keys_str_mv AT stefanoguzzinati characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT saveriovirdone characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT robertadeangelis characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT chiarapanato characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT carlottabuzzoni characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT riccardocapocaccia characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT silviafrancisci characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT annagigli characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT manuelzorzi characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT giovannatagliabue characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT diegoserraino characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT fabiofalcini characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT claudiacasella characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT antoniogiampierorusso characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT fabriziostracci characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT biancacaruso characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT mariamichiara characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT annaluisacaiazzo characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT marinecastaing characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT stefanoferretti characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT luciamangone characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT giusepparudisi characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT flaviosensi characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT guidomazzoleni characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT fabiopannozzo characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT rosariotumino characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT mariofusco characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT paoloricci characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT gemmagola characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT adrianogiacomin characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT francescotisano characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT giuseppacandela characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT annaclarafanetti characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT filomenapala characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT antonellasuterasardo characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT massimorugge characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT laurabotta characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020
AT luiginodalmaso characteristicsofpeoplelivinginitalyafteracancerdiagnosisin2010andprojectionsto2020